Assenagon Asset Management S.A. Puma Biotechnology, Inc. Transaction History
Assenagon Asset Management S.A.
- $65.1 Billion
- Q3 2025
A detailed history of Assenagon Asset Management S.A. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 72,979 shares of PBYI stock, worth $376,571. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,979Holding current value
$376,571% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding PBYI
# of Institutions
125Shares Held
33.7MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$21.3 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$19.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$18.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$10.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.67 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $235M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...